Product
CK-3828136
1 clinical trial
1 indication
Indication
Healthy ParticipantsClinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3828136 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2023-12-01